HD LifeSciences CEO joins Ortho RTI board of directors

Alan Condon -   Print  |

Ortho Regenerative Technologies has welcomed Patrick O' Donnell, president and CEO of HD LifeSciences, to its board of directors.

Mr. O'Donnell has a wealth of experience in company-building, developing strategic partnerships and commercial, clinical, regulatory and reimbursement strategies.

Previously, he served as CEO of orthobiologic company ProteoThera, which he founded, president and CEO of Histogenics, and CEO of ProChon Biotech.

Ortho RTI founders Michael Buschmann, PhD, and Caroline Hoemann, PhD, retired from the board Feb. 22. Dr. Buschmann will remain as chief scientific officer and both will continue to serve on the scientific advisory board.

More articles on devices:
Will disc replacement supersede spinal fusion? 7 spine surgeons weigh in
FDA clears two surgical robots focused on imaging, spine
These CMS changes would significantly improve spine care: 6 surgeons weigh in

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers